W: decision granting a waiver in all age groups for all conditions or indications
Decision date
Decision
P/0244/2016: EMA decision of 9 September 2016 on the granting of a product specific waiver for humanized IgG1, kappa anti-serum amyloid A and anti-
AL amyloid antibody (EMEA-001962-PIP01-16)